| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -27,256,000 | -9,316,786 |
| Non-cash interest expense | 2,496,000 | - |
| Due to related party | - | -8,820 |
| Gain (loss) on change in fair value of related party convertible debt | -198,000 | - |
| Deferred tax liability | - | 0 |
| Noncash issuance of inducement shares in connection with the merger | 7,584,000 | - |
| Income tax payable | - | 0 |
| Noncash issuance of warrants associated with eloc costs | 982,000 | - |
| Accounts payable and accrued expenses | - | 1,060,055 |
| Stock-based compensation expenses | 704,000 | - |
| Interest income on cash held in trust account | - | 95,084 |
| Gain on change in fair value of warrant liabilities | -884,000 | 6,265,530 |
| Prepaid income taxes | - | -20,988 |
| Loss on change in fair value of digital assets | 28,000 | - |
| Prepaid expenses and other current assets | 118,000 | -14,166 |
| Prepaid franchise taxes | - | 15,600 |
| Other non-current assets | -1,000 | - |
| Changes in fair value of securities purchase agreement | - | 193,878 |
| Accounts payable | 3,197,000 | - |
| Changes in fair value of convertible promissory note | - | 1,380,059 |
| Accrued liabilities | 2,345,000 | - |
| Net cash used in operating activities | -11,119,000 | -501,614 |
| Reimbursement of franchise and income taxes from trust account | - | 78,813 |
| Payment of extension fee into trust account | - | 99,285 |
| Cash withdrawn from trust account in connection with redemption | - | 6,510,830 |
| Purchase of digital assets | 1,000,000 | - |
| Net cash used in investing activities | -1,000,000 | 6,490,358 |
| Proceeds from issuance of notes | 1,450,000 | - |
| Proceeds from eloc | 3,537,000 | - |
| Advance from profusa | - | 507,633 |
| Proceeds from issuance of loans payable | 11,000,000 | - |
| Proceeds from convertible promissory note | - | 0 |
| Net cash received from the reverse recapitalization | 2,000 | - |
| Redemption of common stock | - | 6,510,830 |
| Repayment of convertible notes | 1,052,000 | - |
| Net cash provided by financing activities | 14,937,000 | -6,003,197 |
| Net increase (decrease) in cash | 2,818,000 | -14,453 |
| Cash and cash equivalents at beginning of period | 191,000 | - |
| Cash and cash equivalents at end of period | 3,009,000 | - |
Profusa, Inc. (PFSA)
Profusa, Inc. (PFSA)